BioWorld-International-2004-09-29
Qiagen Pays $28.5M Cash For Molecular Staging Technology
Qiagen Pays $28.5M Cash For Molecular Staging Technology
Qiagen NV is paying $28.5 million in cash to acquire whole-genome amplification technology from Molecular Staging Inc. (BioWorld International)

